TY - JOUR
T1 - Dairy Consumption and Risks of Colorectal Cancer Incidence and Mortality
T2 - A Meta-analysis of Prospective Cohort Studies
AU - Jin, Shaoyue
AU - Kim, Youngyo
AU - Je, Youjin
N1 - Publisher Copyright:
©2020 American Association for Cancer Research.
PY - 2020/11/1
Y1 - 2020/11/1
N2 - Background: Previous studies of dairy consumption and colorectal cancer incidence have shown inconsistent results, and there was no meta-analysis of association of dairy consumption with colorectal cancer mortality. Thus, we conducted a comprehensive analysis of prospective cohort studies to investigate these associations. Methods: PubMed and Web of Science databases were searched for eligible studies published up to July 2019, and a random effects model was used to estimate pooled RR. Results: We identified 31 prospective cohort studies, which included 24,964 and 2,302 cases for colorectal cancer incidence and mortality, respectively. The pooled RR of colorectal cancer incidence for the highest versus lowest categories of total dairy consumption was 0.79 [95% confidence interval (CI), 0.74–0.85]. For milk consumption, there was also a significant inverse association (RR, 0.81; 95% CI, 0.76–0.86). For cheese and fermented milk consumption, overall no association was found, but studies conducted in Europe showed a significant inverse association for cheese (RR, 0.87; 95% CI, 0.78–0.97) and fermented milk consumption (RR, 0.91; 95% CI, 0.85–0.98). For colorectal cancer mortality, we found 29% lower risk of death from colorectal cancer in subjects with high dairy consumption compared with those with low intakes of dairy products (RR, 0.71; 95% CI, 0.54–0.93), but each type of dairy consumption did not show a significant association. Conclusions: High dairy consumption was associated with lower colorectal cancer incidence and mortality. Impact: Our findings suggest that high dairy consumption may be associated with lower colorectal cancer incidence and mortality, but further studies are warranted.
AB - Background: Previous studies of dairy consumption and colorectal cancer incidence have shown inconsistent results, and there was no meta-analysis of association of dairy consumption with colorectal cancer mortality. Thus, we conducted a comprehensive analysis of prospective cohort studies to investigate these associations. Methods: PubMed and Web of Science databases were searched for eligible studies published up to July 2019, and a random effects model was used to estimate pooled RR. Results: We identified 31 prospective cohort studies, which included 24,964 and 2,302 cases for colorectal cancer incidence and mortality, respectively. The pooled RR of colorectal cancer incidence for the highest versus lowest categories of total dairy consumption was 0.79 [95% confidence interval (CI), 0.74–0.85]. For milk consumption, there was also a significant inverse association (RR, 0.81; 95% CI, 0.76–0.86). For cheese and fermented milk consumption, overall no association was found, but studies conducted in Europe showed a significant inverse association for cheese (RR, 0.87; 95% CI, 0.78–0.97) and fermented milk consumption (RR, 0.91; 95% CI, 0.85–0.98). For colorectal cancer mortality, we found 29% lower risk of death from colorectal cancer in subjects with high dairy consumption compared with those with low intakes of dairy products (RR, 0.71; 95% CI, 0.54–0.93), but each type of dairy consumption did not show a significant association. Conclusions: High dairy consumption was associated with lower colorectal cancer incidence and mortality. Impact: Our findings suggest that high dairy consumption may be associated with lower colorectal cancer incidence and mortality, but further studies are warranted.
UR - http://www.scopus.com/inward/record.url?scp=85096638065&partnerID=8YFLogxK
U2 - 10.1158/1055-9965.EPI-20-0127
DO - 10.1158/1055-9965.EPI-20-0127
M3 - Article
C2 - 32855265
AN - SCOPUS:85096638065
SN - 1055-9965
VL - 29
SP - 2309
EP - 2322
JO - Cancer Epidemiology Biomarkers and Prevention
JF - Cancer Epidemiology Biomarkers and Prevention
IS - 11
ER -